MTHFR C677T genetic polymorphism in combination with serum vitamin B2, B12 and aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and esophageal precancerous lesions: a case–control study

MLA

Da Pan, et al. “MTHFR C677T Genetic Polymorphism in Combination with Serum Vitamin B2, B12 and Aberrant DNA Methylation of P16 and P53 Genes in Esophageal Squamous Cell Carcinoma and Esophageal Precancerous Lesions: A Case–control Study.” Cancer Cell International, vol. 19, no. 1, Nov. 2019, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12935-019-1012-x.

APA

Da Pan, Ming Su, Guiling Huang, Pengfei Luo, Ting Zhang, Lingmeng Fu, Jie Wei, Shaokang Wang, & Guiju Sun. (2019). MTHFR C677T genetic polymorphism in combination with serum vitamin B2, B12 and aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and esophageal precancerous lesions: a case–control study. Cancer Cell International, 19(1), 1–12. https://doi.org/10.1186/s12935-019-1012-x

Chicago

Da Pan, Ming Su, Guiling Huang, Pengfei Luo, Ting Zhang, Lingmeng Fu, Jie Wei, Shaokang Wang, and Guiju Sun. 2019. “MTHFR C677T Genetic Polymorphism in Combination with Serum Vitamin B2, B12 and Aberrant DNA Methylation of P16 and P53 Genes in Esophageal Squamous Cell Carcinoma and Esophageal Precancerous Lesions: A Case–control Study.” Cancer Cell International 19 (1): 1–12. doi:10.1186/s12935-019-1012-x.